Boundless Bio, Inc. (BOLD)
(Delayed Data from NSDQ)
$10.52 USD
-0.50 (-4.54%)
Updated May 23, 2024 04:00 PM ET
After-Market: $10.47 -0.05 (-0.48%) 6:22 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
BOLD 10.52 -0.50(-4.54%)
Will BOLD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BOLD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for BOLD
Boundless Bio Inc.: A Strong Buy on Robust Pipeline Progress and Financial Stability
Boundless Bio GAAP EPS of -$12.27 misses by $11.54
Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
Boundless Bio Inc. Shifts Corporate Updates to IR Website
Boundless Bio reports Q1 EPS ($12.27) vs. ($9.91) last year